{"parse":{"title":"National Institute for Health and Care Excellence","pageid":429680,"revid":856187413,"text":{"*":"<div class=\"mw-parser-output\"><div role=\"note\" class=\"hatnote navigation-not-searchable\">\"NICE\" redirects here. For other uses, see <a href=\"/wiki/NICE_(disambiguation)\" class=\"mw-disambig\" title=\"NICE (disambiguation)\">NICE (disambiguation)</a>.</div>\n<table class=\"infobox\" style=\"width:22em\"><caption>National Institute for Health and Care Excellence</caption><tbody><tr><td colspan=\"2\" style=\"text-align:center\">\n<a href=\"/wiki/File:National_Institute_for_Health_and_Care_Excellence.svg\" class=\"image\"><img alt=\"National Institute for Health and Care Excellence.svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/44/National_Institute_for_Health_and_Care_Excellence.svg/220px-National_Institute_for_Health_and_Care_Excellence.svg.png\" width=\"220\" height=\"22\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/44/National_Institute_for_Health_and_Care_Excellence.svg/330px-National_Institute_for_Health_and_Care_Excellence.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/44/National_Institute_for_Health_and_Care_Excellence.svg/440px-National_Institute_for_Health_and_Care_Excellence.svg.png 2x\" data-file-width=\"492\" data-file-height=\"50\" /></a></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background-color: #efefef\">Agency overview</th></tr><tr><th scope=\"row\">Headquarters</th><td>\n<a href=\"/wiki/London\" title=\"London\">London</a>, United Kingdom</td></tr><tr><th scope=\"row\">Website</th><td>\n<span class=\"url\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.nice.org.uk\">www<wbr />.nice<wbr />.org<wbr />.uk</a></span></td></tr></tbody></table>\n<table class=\"plainlinks metadata ambox ambox-content ambox-Refimprove\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>needs additional citations for <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verification</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=National_Institute_for_Health_and_Care_Excellence&amp;action=edit\">improve this article</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span>  <small><i>(April 2014)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><div id=\"mwe_player_0\" class=\"PopUpMediaTransform\" style=\"width:220px;\" videopayload=\"&lt;div class=&quot;mediaContainer&quot; style=&quot;width:320px&quot;&gt;&lt;video id=&quot;mwe_player_1&quot; poster=&quot;//upload.wikimedia.org/wikipedia/commons/thumb/0/09/Evidence-informed-health-policy-4---Case-descriptions-of-organizations-that-support-the-use-of-1748-5908-3-56-S8.ogv/320px--Evidence-informed-health-policy-4---Case-descriptions-of-organizations-that-support-the-use-of-1748-5908-3-56-S8.ogv.jpg&quot; controls=&quot;&quot; preload=&quot;none&quot; autoplay=&quot;&quot; style=&quot;width:320px;height:180px&quot; class=&quot;kskin&quot; data-durationhint=&quot;380.694&quot; data-startoffset=&quot;0&quot; data-mwtitle=&quot;Evidence-informed-health-policy-4---Case-descriptions-of-organizations-that-support-the-use-of-1748-5908-3-56-S8.ogv&quot; data-mwprovider=&quot;wikimediacommons&quot;&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/0/09/Evidence-informed-health-policy-4---Case-descriptions-of-organizations-that-support-the-use-of-1748-5908-3-56-S8.ogv/Evidence-informed-health-policy-4---Case-descriptions-of-organizations-that-support-the-use-of-1748-5908-3-56-S8.ogv.180p.vp9.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp9, opus&amp;quot;&quot; data-title=&quot;Low bandwidth VP9 (180P)&quot; data-shorttitle=&quot;VP9 180P&quot; data-transcodekey=&quot;180p.vp9.webm&quot; data-width=&quot;320&quot; data-height=&quot;180&quot; data-bandwidth=&quot;250112&quot; data-framerate=&quot;30.00003000003&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/0/09/Evidence-informed-health-policy-4---Case-descriptions-of-organizations-that-support-the-use-of-1748-5908-3-56-S8.ogv&quot; type=&quot;video/ogg; codecs=&amp;quot;theora, vorbis&amp;quot;&quot; data-title=&quot;Original Ogg file, 320 \u00d7 180 (481 kbps)&quot; data-shorttitle=&quot;Ogg source&quot; data-width=&quot;320&quot; data-height=&quot;180&quot; data-bandwidth=&quot;480794&quot; data-framerate=&quot;30.00003000003&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/0/09/Evidence-informed-health-policy-4---Case-descriptions-of-organizations-that-support-the-use-of-1748-5908-3-56-S8.ogv/Evidence-informed-health-policy-4---Case-descriptions-of-organizations-that-support-the-use-of-1748-5908-3-56-S8.ogv.120p.vp9.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp9, opus&amp;quot;&quot; data-title=&quot;Lowest bandwidth VP9 (120P)&quot; data-shorttitle=&quot;VP9 120P&quot; data-transcodekey=&quot;120p.vp9.webm&quot; data-width=&quot;214&quot; data-height=&quot;120&quot; data-bandwidth=&quot;175480&quot; data-framerate=&quot;30.00003000003&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/0/09/Evidence-informed-health-policy-4---Case-descriptions-of-organizations-that-support-the-use-of-1748-5908-3-56-S8.ogv/Evidence-informed-health-policy-4---Case-descriptions-of-organizations-that-support-the-use-of-1748-5908-3-56-S8.ogv.160p.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp8, vorbis&amp;quot;&quot; data-title=&quot;Low bandwidth WebM (160P)&quot; data-shorttitle=&quot;WebM 160P&quot; data-transcodekey=&quot;160p.webm&quot; data-width=&quot;284&quot; data-height=&quot;160&quot; data-bandwidth=&quot;202328&quot; data-framerate=&quot;30.00003000003&quot;/&gt;&lt;/video&gt;&lt;/div&gt;\"><img alt=\"File:Evidence-informed-health-policy-4---Case-descriptions-of-organizations-that-support-the-use-of-1748-5908-3-56-S8.ogv\" style=\"width:220px;height:124px\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/0/09/Evidence-informed-health-policy-4---Case-descriptions-of-organizations-that-support-the-use-of-1748-5908-3-56-S8.ogv/220px-seek%3D102-Evidence-informed-health-policy-4---Case-descriptions-of-organizations-that-support-the-use-of-1748-5908-3-56-S8.ogv.jpg\" /><a href=\"//upload.wikimedia.org/wikipedia/commons/0/09/Evidence-informed-health-policy-4---Case-descriptions-of-organizations-that-support-the-use-of-1748-5908-3-56-S8.ogv\" title=\"Play media\" target=\"new\"><span class=\"play-btn-large\"><span class=\"mw-tmh-playtext\">Play media</span></span></a></div>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Evidence-informed-health-policy-4---Case-descriptions-of-organizations-that-support-the-use-of-1748-5908-3-56-S8.ogv\" class=\"internal\" title=\"Enlarge\"></a></div>A six-minute video documentary of NICE from 2008.</div></div></div>\n<p>The <b>National Institute for Health and Care Excellence</b> (<b>NICE</b>) is an executive <a href=\"/wiki/Non-departmental_public_body\" title=\"Non-departmental public body\">non-departmental public body</a> of the <a href=\"/wiki/Department_of_Health_(United_Kingdom)\" class=\"mw-redirect\" title=\"Department of Health (United Kingdom)\">Department of Health</a> in the <a href=\"/wiki/United_Kingdom\" title=\"United Kingdom\">United Kingdom</a>,<sup id=\"cite_ref-Committee2013_1-0\" class=\"reference\"><a href=\"#cite_note-Committee2013-1\">&#91;1&#93;</a></sup> which publishes guidelines in four areas:<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup> \n</p>\n<ul><li>the use of <a href=\"/wiki/Health_technology\" class=\"mw-redirect\" title=\"Health technology\">health technologies</a> within the NHS (such as the use of new and existing medicines, treatments and procedures)</li>\n<li>clinical practice (guidance on the appropriate treatment and care of people with specific diseases and conditions)</li>\n<li>guidance for public sector workers on <a href=\"/wiki/Health_promotion\" title=\"Health promotion\">health promotion</a> and ill-health avoidance</li>\n<li>guidance for social care services and users.</li></ul>\n<p>These appraisals are based primarily on evaluations of efficacy and cost-effectiveness in various circumstances.\n</p><p>It serves both the <a href=\"/wiki/National_Health_Service_(England)\" title=\"National Health Service (England)\">English NHS</a> and the <a href=\"/wiki/Welsh_NHS\" class=\"mw-redirect\" title=\"Welsh NHS\">Welsh NHS</a>.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup> It was set up as the <b>National Institute for Clinical Excellence</b> in 1999, and on 1 April 2005 joined with the <b>Health Development Agency</b> to become the new <b>National Institute for Health and Clinical Excellence</b> (still abbreviated as NICE).<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup> Following the <a href=\"/wiki/Health_and_Social_Care_Act_2012\" title=\"Health and Social Care Act 2012\">Health and Social Care Act 2012</a>, NICE was renamed the National Institute for Health and Care Excellence on 1 April 2013 reflecting its new responsibilities for social care, and changed from a <a href=\"/wiki/NHS_special_health_authority\" title=\"NHS special health authority\">special health authority</a> to an Executive Non-Departmental Public Body (ENDPB).\n</p><p>NICE was established in an attempt to end the so-called <a href=\"/wiki/Postcode_lottery\" title=\"Postcode lottery\">postcode lottery</a> of healthcare in England and Wales, where treatments that were available depended upon the NHS Health Authority area in which the patient happened to live, but it has since acquired a high reputation internationally as a role model for the development of clinical guidelines. One aspect of this is the explicit determination of cost\u2013benefit boundaries for certain technologies that it assesses.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup> NICE also plays an important role in pioneering technology assessment in other healthcare systems through NICE International, established in May 2008 to help cultivate links with foreign governments.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup><sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Policy_history\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Policy history</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Technology_appraisals\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Technology appraisals</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Clinical_guidelines\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Clinical guidelines</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Social_care_guidance\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Social care guidance</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Cost\u2013effectiveness\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Cost\u2013effectiveness</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Quality-adjusted_life_years\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">Quality-adjusted life years</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Cost_per_quality-adjusted_life_year_gained\"><span class=\"tocnumber\">5.2</span> <span class=\"toctext\">Cost per quality-adjusted life year gained</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Basis_of_recommendations\"><span class=\"tocnumber\">5.3</span> <span class=\"toctext\">Basis of recommendations</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#Criticism\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Criticism</span></a></li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#See_also\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#References\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#Further_reading\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">Further reading</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Policy_history\">Policy history</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=National_Institute_for_Health_and_Care_Excellence&amp;action=edit&amp;section=1\" title=\"Edit section: Policy history\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The notion of an Institute to determine the clinical effectiveness of interventions first emerged at the end of <a href=\"/wiki/John_Major\" title=\"John Major\">John Major</a>'s Conservative Government as moves elsewhere<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Naming_conventions_(geographic_names)\" title=\"Wikipedia:Naming conventions (geographic names)\"><span title=\"The geographic scope near this tag is ambiguous. (July 2013)\">where?</span></a></i>&#93;</sup> were being made to set professionally agreed standards for clinical care. In 1996, the <a href=\"/wiki/UK_National_Screening_Committee\" title=\"UK National Screening Committee\">UK National Screening Committee</a> (NSC) had been established by <a href=\"/wiki/Kenneth_Calman\" title=\"Kenneth Calman\">Sir Kenneth Calman</a> and <a href=\"/wiki/Muir_Gray\" title=\"Muir Gray\">Muir Gray</a> (now Sir Muir Gray) by the Policy Team led by Dr Tim Riley and latterly Sir Charles Nightingale for the Department of Health.<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup> The NSC aimed to ensure that evidence-based medicine informed policy making on what national screening programmes were approved for funding and what quality assurance mechanisms should be in place. This was a timely action as concerns over screening quality had emerged in breast cancer screening services came under question at Exeter in 1997<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup> and followed in the wake of the 1995 <a href=\"/wiki/Calman-Hine_report\" class=\"mw-redirect\" title=\"Calman-Hine report\">Calman-Hine Report</a>.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup>\n</p><p>The idea of what was originally termed a National Institute for Clinical Excellence took root when Labour came to power having in 1997. <a href=\"/wiki/Frank_Dobson\" title=\"Frank Dobson\">Frank Dobson</a> became Secretary of State and was supported by a team of Ministers keen on introducing clinical and health outcome measures to achieve improvements in the quality and delivery of care. The team included <a href=\"/wiki/Alan_Milburn\" title=\"Alan Milburn\">Alan Milburn</a>, <a href=\"/wiki/Margaret_Jay,_Baroness_Jay_of_Paddington\" title=\"Margaret Jay, Baroness Jay of Paddington\">Baroness Margaret Jay</a>, and <a href=\"/wiki/Tessa_Jowell\" title=\"Tessa Jowell\">Tessa Jowell</a>. The name and mission was agreed in a meeting between the Ministerial team, Dr Tim Riley and Dr Felicity Harvey shortly after the election and it was agreed that NICE should be described in the first policy <a href=\"/wiki/White_paper\" title=\"White paper\">white paper</a>, The New NHS: Modern, Dependable 1997.<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup> Riley led the team that developed the policy for NICE and which managed the legislation through Parliament in addition to formalising the new institute as a <a href=\"/wiki/NHS_special_health_authority\" title=\"NHS special health authority\">Special Health Authority</a>. Riley joined <a href=\"/wiki/Michael_Rawlins\" title=\"Michael Rawlins\">Sir Michael Rawlins</a> (the then recently appointed Chair of NICE) at the <a href=\"/wiki/Health_Select_Committee\" title=\"Health Select Committee\">Health Select Committee</a> in February 1999 where questions were raised as to whether NICE was just a means to \"ration\" healthcare. Sir Michael Rawlins presented a compelling case that positioned NICE as a standards setting body first and foremost.<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup> \nHowever, the reality was that although NICE was principally aimed at aligning professional standards through clinical guidelines and audit, the acceptability of drugs, devices and technological interventions in defining those standards, could not be ignored and so the concept of a \"fourth hurdle\" for drugs accessing the NHS market was invoked. This controversial policy shift meant that NICE was critical for decisions on drug reimbursement. Indeed, the first drug appraisal by NICE was on the drug <a href=\"/wiki/Relenza\" class=\"mw-redirect\" title=\"Relenza\">Relenza</a> which was turned down amidst criticisms from <a href=\"/wiki/Glaxo_Wellcome\" class=\"mw-redirect\" title=\"Glaxo Wellcome\">Glaxo-Wellcome</a> that the appraisal had been fast tracked.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup> Later, this policy development whereby the criteria for decision making, the role of costs, and the degree to which decisions of NICE and the secretary of state would be binding on clinicians was analysed by <a href=\"/wiki/Andrew_Dillon\" title=\"Andrew Dillon\">Andrew Dillon</a>, Trevor Gibbs, Tim Riley, and <a href=\"/wiki/Trevor_Sheldon\" title=\"Trevor Sheldon\">Trevor A. Sheldon</a>.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Technology_appraisals\">Technology appraisals</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=National_Institute_for_Health_and_Care_Excellence&amp;action=edit&amp;section=2\" title=\"Edit section: Technology appraisals\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Since January 2005, the NHS in <a href=\"/wiki/NHS_England\" title=\"NHS England\">England</a> and <a href=\"/wiki/NHS_Wales\" title=\"NHS Wales\">Wales</a> has been legally obliged to provide funding for medicines and treatments recommended by NICE's technology appraisal board.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup> This was at least in part as a result of well-publicised postcode lottery anomalies in which certain less-common treatments were funded in some parts of the UK but not in others due to local decision making in the NHS.\n</p><p>Before an appraisal, the Advisory Committee on Topic Selection (ACTS) draws up a list of potential topics of clinical significance for appraisal. The <a href=\"/wiki/Secretary_of_State_for_Health\" class=\"mw-redirect\" title=\"Secretary of State for Health\">Secretary of State for Health</a> or the <a href=\"/wiki/Welsh_Assembly\" class=\"mw-redirect\" title=\"Welsh Assembly\">Welsh Assembly</a> must then refer any technology so that the appraisal process can be formally initiated. Once this has been done NICE works with the Department of Health to draw up the scope of the appraisal.\n</p><p>NICE then invites consultee and commentator organisations to take part in the appraisal. A consultee organisation would include patient groups, organisations representing health care professionals and the manufacturers of the product undergoing appraisal. Consultees submit evidence during the appraisal and comment on the appraisal documents. Commentator organisations include the manufacturers of products to which the product undergoing appraisal is being compared. They comment on the documents that have been submitted and drawn up but do not actually submit information themselves.\n</p><p>An independent academic centre then draws together and analyses all of the published information on the technology under appraisal and prepares an assessment report. This can be commented on by the Consultees and Commentators. Comments are then taken into account and changes made to the assessment report to produce an evaluation report. An independent Appraisal Committee then looks at the evaluation report, hears spoken testimony from clinical experts, patient groups and carers. They take their testimony into account and draw up a document known as the 'appraisal consultation document'. This is sent to all consultees and commentators who are then able to make further comments. Once these comments have been taken into account the final document is drawn up called the 'final appraisal determination'. This is submitted to NICE for approval.\n</p><p>The process aims to be fully independent of government and lobbying power, basing decisions fully on clinical and cost-effectiveness. There have been concerns that <a href=\"/wiki/Lobbying\" title=\"Lobbying\">lobbying</a> by pharmaceutical companies to mobilise media attention and influence public opinion are attempts to influence the decision-making process.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup> A fast-track assessment system has been introduced to reach decisions where there is most pressure for a conclusion.\n</p>\n<h2><span class=\"mw-headline\" id=\"Clinical_guidelines\">Clinical guidelines</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=National_Institute_for_Health_and_Care_Excellence&amp;action=edit&amp;section=3\" title=\"Edit section: Clinical guidelines\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>NICE carries out assessments of the most appropriate treatment regimes for different diseases. This must take into account both desired medical outcomes (i.e. the best possible result for the patient) and also economic arguments regarding differing treatments.\n</p><p>NICE has set up several National Collaborating Centres bringing together expertise from the royal medical colleges, professional bodies and patient/carer organisations which draw up the guidelines. The centres are the <a href=\"/w/index.php?title=National_Collaborating_Centre_for_Cancer&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"National Collaborating Centre for Cancer (page does not exist)\">National Collaborating Centre for Cancer</a>, the <a href=\"/wiki/National_Clinical_Guideline_Centre\" title=\"National Clinical Guideline Centre\">National Clinical Guideline Centre</a>, the <a href=\"/w/index.php?title=National_Collaborating_Centre_for_Women_and_Children%C2%B4s_Health&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"National Collaborating Centre for Women and Children\u00b4s Health (page does not exist)\">National Collaborating Centre for Women and Children\u00b4s Health</a>, and the <a href=\"/wiki/National_Collaborating_Centre_for_Mental_Health\" title=\"National Collaborating Centre for Mental Health\">National Collaborating Centre for Mental Health</a>.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup>\n</p><p>The National Collaborating Centre appoints a Guideline Development Group whose job it is to work on the development of the clinical guideline. This group consists of medical professionals, representatives of patient and carer groups and technical experts. They work together to assess the evidence for the guideline topic (e.g. <a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">clinical trials</a> of competing products) before preparing a draft guideline. There are then two consultation periods in which stakeholder organisations are able to comment on the draft guideline. After the second consultation period, an independent Guideline Review Panel reviews the guideline and stakeholder comments and ensures that these comments have been taken into account. The Guideline Development Group then finalises the recommendations and the National Collaboration Centre produces the final guideline. This is submitted to NICE to formally approve the guideline and issue the guidance to the NHS.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (April 2014)\">citation needed</span></a></i>&#93;</sup> To date NICE has produced more than 200 different guidelines.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup>\n</p><p>In October 2014 <a href=\"/wiki/Andy_Burnham\" title=\"Andy Burnham\">Andy Burnham</a> said that a Labour government could reduce variation in access to drugs and procedures by making it mandatory for commissioners to follow NICE clinical guidelines. \"We need to look at how you strengthen NICE. Where they have said something is effective and affordable, on what basis does a local commissioner withhold that from somebody? I\u2019m not comfortable with that. I don\u2019t support that.\"<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup>\n</p><p>NICE has a service called Clinical Knowledge Summaries (CKS) which provides primary care practitioners with a readily accessible summary of the current evidence base and practical guidance.<sup id=\"cite_ref-Smith2008_21-0\" class=\"reference\"><a href=\"#cite_note-Smith2008-21\">&#91;21&#93;</a></sup><sup id=\"cite_ref-ReesSmith2014_22-0\" class=\"reference\"><a href=\"#cite_note-ReesSmith2014-22\">&#91;22&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Social_care_guidance\">Social care guidance</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=National_Institute_for_Health_and_Care_Excellence&amp;action=edit&amp;section=4\" title=\"Edit section: Social care guidance\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"plainlinks metadata ambox ambox-content ambox-Unreferenced\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>does not <a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\">cite</a> any <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">sources</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=National_Institute_for_Health_and_Care_Excellence&amp;action=edit\">improve this section</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and <a href=\"/wiki/Wikipedia:Verifiability#Burden_of_evidence\" title=\"Wikipedia:Verifiability\">removed</a>.</span>  <small><i>(September 2013)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p>Under the <a href=\"/wiki/Health_and_Social_Care_Act_2012\" title=\"Health and Social Care Act 2012\">Health and Social Care Act</a> 2012, NICE was given responsibility for developing guidance and quality standards for <a href=\"/wiki/Social_care\" class=\"mw-redirect\" title=\"Social care\">social care</a>, using an evidence-based model. This is being delivered by the NICE Collaborating Centre for Social Care (NCCSC), which is hosted by the <a href=\"/wiki/Social_Care_Institute_for_Excellence\" title=\"Social Care Institute for Excellence\">Social Care Institute for Excellence</a> (SCIE) and 4 partner organisations - Research in Practice, Research in Practice for Adults, <a href=\"/w/index.php?title=Personal_Social_Services_Research_Unit&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Personal Social Services Research Unit (page does not exist)\">Personal Social Services Research Unit</a> and the <a href=\"/wiki/EPPI-Centre\" title=\"EPPI-Centre\">EPPI-Centre</a>.\n</p><p>NICE receives referrals for social care guidance from the Department of Health and the <a href=\"/wiki/Department_for_Education\" title=\"Department for Education\">Department for Education</a>, and commission the guidance from the NCCSC. NICE, along with the NCCSC, carries out a scoping exercise with a scoping group and with input from key stakeholders, at both a workshop and a public consultation, to ensure the guidance to be produced is focused and achievable. A <a href=\"/wiki/Chairman\" title=\"Chairman\">chairperson</a> and members of the Guidance Development Group are appointed, and pose review questions which will enable systematic evidence reviews to take place, thus delivering the guidance and subsequent recommendations. Service user and carer involvement takes place throughout, as well as public consultation on the draft guidance.\n</p><p>The Guidance Development Group then finalises the recommendations and the NCCSC produces the final guideline. This is submitted to NICE for formal approval and publication. The entire process from pre-scoping to publication takes approximately 24 months. The guidance is then available to NICE standing committees to develop a quality standard on the topic. The quality standard is developed using the guidance and other accredited sources, to produce high-level concise statements that can be used for quality improvement by social care providers and commissioners, as well as setting out what service users and carers can expect of high quality social care services.\n</p><p>The NCCSC is unique within NICE, in that it is the only collaborating centre to have responsibility for the adoption and dissemination support for guidance and quality standards in the <a href=\"/wiki/Social_work\" title=\"Social work\">social care arena</a>. Drawing on the expertise of SCIE and their partners within the sector, each of the guidance products and quality standards have a needs assessment carried out to determine the requirements for tools to help embed the guidance and quality standards within the sector. These can include tailored versions of guidance for specific audiences, costing and commissioning tools and even training and learning packages.\n</p><p>As of August 2013, NICE and the NCCSC had scheduled guidance delivery for five topics: <a href=\"/wiki/Home_care\" title=\"Home care\">domiciliary care</a>, older adults with long-term conditions, transition between health and social care settings, transition from children's to adults' services and child abuse and neglect.\n</p>\n<h2><span id=\"Cost.E2.80.93effectiveness\"></span><span class=\"mw-headline\" id=\"Cost\u2013effectiveness\">Cost\u2013effectiveness</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=National_Institute_for_Health_and_Care_Excellence&amp;action=edit&amp;section=5\" title=\"Edit section: Cost\u2013effectiveness\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>As with any system financing health care, the NHS has a limited budget and a vast number of potential spending options. Choices must be made as to how this limited budget is spent. <a href=\"/wiki/Economic_evaluation\" title=\"Economic evaluation\">Economic evaluations</a> are carried out within a <a href=\"/wiki/Health_technology_assessment\" title=\"Health technology assessment\">health technology assessment</a> framework to compare the cost-effectiveness of alternative activities and to consider the <a href=\"/wiki/Opportunity_cost\" title=\"Opportunity cost\">opportunity cost</a> associated with their decisions.<sup id=\"cite_ref-Health_Care_Programmes_2005_23-0\" class=\"reference\"><a href=\"#cite_note-Health_Care_Programmes_2005-23\">&#91;23&#93;</a></sup> By choosing to spend the finite NHS budget upon those treatment options that provide the most efficient results, society can ensure it does not lose out on possible health gains through spending on inefficient treatments and neglecting those that are more efficient.\n</p><p>NICE attempts to assess the cost\u2013effectiveness of potential expenditures within the NHS to assess whether or not they represent 'better value' for money than treatments that would be neglected if the expenditure took place. It assesses the cost\u2013effectiveness of new treatments by analysing the cost and benefit of the proposed treatment relative to the next best treatment that is currently in use.<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Quality-adjusted_life_years\">Quality-adjusted life years</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=National_Institute_for_Health_and_Care_Excellence&amp;action=edit&amp;section=6\" title=\"Edit section: Quality-adjusted life years\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>NICE guidance supports the use of <a href=\"/wiki/Quality-adjusted_life_year\" title=\"Quality-adjusted life year\">quality-adjusted life years</a> (QALY) as the primary outcome for quantifying the expected health benefits associated with a given treatment regime. By comparing the present value (see <a href=\"/wiki/Discounting\" title=\"Discounting\">discounting</a>) of expected QALY flows with and without treatment, or relative to another treatment, the net/relative health benefit derived from such a treatment can be derived. When combined with the relative cost of treatment, this information can be used to estimate an <a href=\"/wiki/Incremental_cost-effectiveness_ratio\" title=\"Incremental cost-effectiveness ratio\">incremental cost-effectiveness ratio</a> (ICER), which is considered in relation to NICE's threshold willingness-to-pay value.<sup id=\"cite_ref-Health_Care_Programmes_2005_23-1\" class=\"reference\"><a href=\"#cite_note-Health_Care_Programmes_2005-23\">&#91;23&#93;</a></sup>\n</p><p>As a guideline rule, NICE accepts as cost-effective those interventions with an incremental cost-effectiveness ratio of less than \u00a320,000 per QALY and that there should be increasingly strong reasons for accepting as cost-effective interventions with an incremental cost-effectiveness ratio of over a threshold of \u00a330,000 per QALY.<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup>\n</p><p>Over the years, there has been great controversy as to what value this threshold should be set at. Initially, there was no fixed number. But the appraisal teams created a consensus amount of about \u00a330,000. However, in November 2008 <a href=\"/wiki/Alan_Johnson\" title=\"Alan Johnson\">Alan Johnson</a>, the then Secretary of State, announced that for end-of-life cancer drugs the threshold could be increased above \u00a330,000. \n<sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup>\n</p><p>The first drug to go through the new process was <a href=\"/wiki/Lenalidomide\" title=\"Lenalidomide\">Lenalidomide</a>, whose ICER was \u00a343,800.<sup id=\"cite_ref-27\" class=\"reference\"><a href=\"#cite_note-27\">&#91;27&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Cost_per_quality-adjusted_life_year_gained\">Cost per quality-adjusted life year gained</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=National_Institute_for_Health_and_Care_Excellence&amp;action=edit&amp;section=7\" title=\"Edit section: Cost per quality-adjusted life year gained\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The following example from NICE explains the QALY principle and the application of the cost per QALY calculation.\n</p><p>A patient has a life-threatening condition and is expected to live on average for 1 year receiving the current best treatment which costs the NHS \u00a33,000. A new drug becomes available that will extend the life of the patient by three months and improve his or her quality of life, but the new treatment will cost the NHS more than three times as much at \u00a310,000. Patients score their perceived quality of life on a scale from 0 to 1 with 0 being worst possible health and 1 being best possible health. On the standard treatment, quality of life is rated with a score of 0.4 but it improves to 0.6 with the new treatment. Patients on the new treatment on average live an extra 3 months, so 1.25 years in total. The quality of life gained is the product of <i>life span</i> and <i>quality rating</i> with the new treatment less the same calculation for the old treatment, i.e. <span>(1.25 x 0.6)</span> less <span>(1.0 x 0.4)</span> = 0.35 QALY. The marginal cost of the new treatment to deliver this extra gain is \u00a37,000 so the cost per quality life year gained is \u00a37000/0.35 or \u00a320,000. This is within the \u00a320,000-\u00a330,000 that is suggested by NICE to be the limit for drugs to be cost-effective.<sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup>\n</p><p>If the patient was expected to live only one month extra and instead of three then NICE would issue a recommendation not to fund. The patient's <a href=\"/wiki/NHS_primary_care_trust\" title=\"NHS primary care trust\">Primary Care Trust</a><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Manual_of_Style/Dates_and_numbers#Chronological_items\" title=\"Wikipedia:Manual of Style/Dates and numbers\"><span title=\"The date of the event predicted near this tag has passed. (December 2014)\">needs update</span></a></i>&#93;</sup> could still decide to fund the new treatment, but if not, the patient would then have two choices. He or she could opt to take the free NHS standard treatment, or he or she may decide to pay out of pocket to obtain the benefit of the new treatment from a different health care provider. If the person has a private health insurance policy the person could check to see whether the private insurance provider will fund the new treatment. About 8% of the population has some private health insurance from an employer or trade association and 2% pay from their own resources.\n</p>\n<h3><span class=\"mw-headline\" id=\"Basis_of_recommendations\">Basis of recommendations</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=National_Institute_for_Health_and_Care_Excellence&amp;action=edit&amp;section=8\" title=\"Edit section: Basis of recommendations\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Theoretically, it might be possible to draw up a table of all possible treatments sorted by increasing the cost per quality-adjusted life year gained. Those treatments with lowest cost per quality-adjusted life year gained would appear at the top of the table and deliver the most benefit per value spent and would be easiest to justify funding for. Those where the delivered benefit is low and the cost is high would appear at the bottom of the list. Decision makers would, theoretically, work down the table, adopting services that are the most cost effective. The point at which the NHS budget is exhausted would reveal the <a href=\"/wiki/Shadow_price\" title=\"Shadow price\">shadow price</a>, the threshold lying between the CQG gained of the last service that is funded and that of the next most cost effective service that is not funded.\n</p><p>In practice this exercise is not done, but an assumed shadow price has been used by NICE for many years in its assessments to determine which treatments the NHS should and should not fund. NICE states that for drugs the cost per QALY should not normally exceed \u00a330,000 but that there is not a hard threshold,<sup id=\"cite_ref-Quality_Adjusted_Life_Year_29-0\" class=\"reference\"><a href=\"#cite_note-Quality_Adjusted_Life_Year-29\">&#91;29&#93;</a></sup> though research has shown that any threshold is \"somewhat higher\" than being in the range \u00a335,000 - \u00a340,000.<sup id=\"cite_ref-Quality_Adjusted_Life_Year_29-1\" class=\"reference\"><a href=\"#cite_note-Quality_Adjusted_Life_Year-29\">&#91;29&#93;</a></sup><sup id=\"cite_ref-30\" class=\"reference\"><a href=\"#cite_note-30\">&#91;30&#93;</a></sup>\n</p><p>The <a href=\"/wiki/Health_Select_Committee\" title=\"Health Select Committee\">House of Commons Health Select Committee</a>, in its report on NICE, stated in 2008 that \"the (...) cost-per-QALY it uses to decide whether a treatment is cost-effective is of serious concern. The threshold it employs is not based on empirical research and is not directly related to the NHS budget, nor is it at the same level as that used by Primary Care Trusts (PCTs) in providing treatments not assessed by NICE, which tends to be lower. Some witnesses, including patient organisations and pharmaceutical companies, thought NICE should be more generous in the cost per QALY threshold it uses, and should approve more products. On the other hand, some PCTs struggle to implement NICE guidance at the current threshold and other witnesses argued that a lower level should be used. However, there are many uncertainties about the thresholds used by PCTs.\" It went on to recommend that \"an independent body should determine the threshold used when making judgements of the value of drugs to the NHS.\"<sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Criticism\">Criticism</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=National_Institute_for_Health_and_Care_Excellence&amp;action=edit&amp;section=9\" title=\"Edit section: Criticism\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The work that NICE is involved in attracts the attention of many groups, including doctors, the pharmaceutical industry, and patients. NICE is often associated with controversy, because the need to make decisions at a national level can conflict with what is (or is believed to be) in the best interests of an individual patient.\n</p><p>Approved cancer drugs and treatments such as <a href=\"/wiki/Radiotherapy\" class=\"mw-redirect\" title=\"Radiotherapy\">radiotherapy</a> and <a href=\"/wiki/Chemotherapy\" title=\"Chemotherapy\">chemotherapy</a> are funded by the NHS without any financial contribution being taken from the patient. Where NICE has approved a treatment, the NHS must fund it. But not all treatments have been assessed by NICE and these treatments are usually dependent on local NHS decision making. In the case of cancer the <a href=\"/wiki/Cancer_Drugs_Fund\" title=\"Cancer Drugs Fund\">Cancer Drugs Fund</a> was set up in 2011 after complaints about NICE decisions on new and expensive cancer drugs with limited benefits.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (October 2014)\">citation needed</span></a></i>&#93;</sup> Treatment for fertility problems are approved but not always funded by <a href=\"/wiki/Clinical_commissioning_group\" title=\"Clinical commissioning group\">clinical commissioning groups</a> and they may cap the number of rounds.<sup id=\"cite_ref-32\" class=\"reference\"><a href=\"#cite_note-32\">&#91;32&#93;</a></sup>\n</p><p>NICE has been criticised for being too slow to reach decisions. On one occasion, the <a href=\"/wiki/Royal_National_Institute_of_Blind_People\" title=\"Royal National Institute of Blind People\">Royal National Institute of Blind People</a> said it was outraged over its delayed decision for further guidance regarding two drugs for <a href=\"/wiki/Macular_degeneration\" title=\"Macular degeneration\">macular degeneration</a> that are already approved for use in the NHS. However the Department of Health said that it had 'made it clear to PCTs that funding for treatments should not be withheld simply because guidance from NICE is unavailable'.<sup id=\"cite_ref-33\" class=\"reference\"><a href=\"#cite_note-33\">&#91;33&#93;</a></sup>\n</p><p>Some of the more controversial NICE decisions have concerned <a href=\"/wiki/Donepezil\" title=\"Donepezil\">donepezil</a>, <a href=\"/wiki/Galantamine\" title=\"Galantamine\">galantamine</a>, <a href=\"/wiki/Rivastigmine\" title=\"Rivastigmine\">rivastigmine</a> (review) and <a href=\"/wiki/Memantine\" title=\"Memantine\">memantine</a> for the treatment of <a href=\"/wiki/Alzheimer%27s_disease\" title=\"Alzheimer&#39;s disease\">Alzheimer's disease</a> and <a href=\"/wiki/Bevacizumab\" title=\"Bevacizumab\">bevacizumab</a>, <a href=\"/wiki/Sorafenib\" title=\"Sorafenib\">sorafenib</a>, <a href=\"/wiki/Sunitinib\" title=\"Sunitinib\">sunitinib</a> and <a href=\"/wiki/Temsirolimus\" title=\"Temsirolimus\">temsirolimus</a> for <a href=\"/wiki/Renal_cell_carcinoma\" title=\"Renal cell carcinoma\">renal cell carcinoma</a>. All these are drugs with a high cost per treatment and NICE has either rejected or restricted their use in the NHS on the grounds that they are not cost-effective.\n</p><p>A Conservative shadow minister once criticized NICE for spending more on communications than assessments. In its defence, NICE said the majority of its communications budget was spent informing doctors about which drugs had been approved and new guidelines for treatments and that the actual cost of assessing new drugs for the NHS includes money spent on NICE's behalf by the Department of Health. When these were added to NICE's own costs, the total cost of the technology appraisal programme far outstrips the cost of NICE communications.\n</p><p>A report from the <a href=\"/wiki/University_of_York\" title=\"University of York\">University of York</a> Centre for Health Economics written by <a href=\"/wiki/Karl_Claxton\" title=\"Karl Claxton\">Karl Claxton</a> in February 2015 suggested that the maximum threshold, currently around \u00a330,000 a year, for judging a medicine cost-effective should be more than halved. They found that any intervention costing more than \u00a313,000 per <a href=\"/wiki/Quality-adjusted_life_year\" title=\"Quality-adjusted life year\">Quality-adjusted life year</a> risked causing more harm than good by denying cost effective treatment to other patients.<sup id=\"cite_ref-34\" class=\"reference\"><a href=\"#cite_note-34\">&#91;34&#93;</a></sup>\n</p><p>The institute's approach to the introduction of new oral therapy for <a href=\"/wiki/Hepatitis_C\" title=\"Hepatitis C\">Hepatitis C</a> has been criticised. <a href=\"/wiki/Sofosbuvir\" title=\"Sofosbuvir\">Sofosbuvir</a> was approved in 2015. It costs about \u00a330,000 for 12 weeks treatment. <a href=\"/wiki/NHS_England\" title=\"NHS England\">NHS England</a> established 22 Operational Delivery Networks to roll out delivery and proposes to fund 10,000 courses of treatment in 2016-17. Each has been given a \u201crun rate\u201d of how many patients they are allowed to treat. This is the NHS\u2019 single biggest new treatment investment this year.<sup id=\"cite_ref-35\" class=\"reference\"><a href=\"#cite_note-35\">&#91;35&#93;</a></sup> In the North East London network patients with <a href=\"/wiki/Cirrhosis\" title=\"Cirrhosis\">cirrhosis</a> or <a href=\"/wiki/Fibrosis\" title=\"Fibrosis\">fibrosis</a> go to the front of the queue and three new patients at the Grahame Hayton Unit at the <a href=\"/wiki/Royal_London_Hospital\" title=\"Royal London Hospital\">Royal London Hospital</a> start treatment each month. Those without such complications may faced considerable delays before they start treatment.<sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=National_Institute_for_Health_and_Care_Excellence&amp;action=edit&amp;section=10\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Health_care_rationing\" title=\"Health care rationing\">Health care rationing</a></li>\n<li><a href=\"/wiki/National_Institute_for_Health_Research\" title=\"National Institute for Health Research\">National Institute for Health Research</a></li>\n<li><a href=\"/wiki/Scottish_Intercollegiate_Guideline_Network\" class=\"mw-redirect\" title=\"Scottish Intercollegiate Guideline Network\">Scottish Intercollegiate Guideline Network</a> which has produced treatment guidelines since 1995 on over 120 conditions</li>\n<li><a href=\"/wiki/Scottish_Medicines_Consortium\" class=\"mw-redirect\" title=\"Scottish Medicines Consortium\">Scottish Medicines Consortium</a> which deals with similar matters in Scotland</li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=National_Institute_for_Health_and_Care_Excellence&amp;action=edit&amp;section=11\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-Committee2013-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Committee2013_1-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Great Britain: Parliament: House of Commons: Health Committee (2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=3d-bsIthzCYC&amp;pg=PA7\"><i>National Institute for Health and Clinical Excellence: Eighth Report of Session 2012-13, Vol. 1: Report,</i></a>. The Stationery Office. p.&#160;7. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-215-05239-1\" title=\"Special:BookSources/978-0-215-05239-1\">978-0-215-05239-1</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=National+Institute+for+Health+and+Clinical+Excellence%3A+Eighth+Report+of+Session+2012-13%2C+Vol.+1%3A+Report%2C&amp;rft.pages=7&amp;rft.pub=The+Stationery+Office&amp;rft.date=2013&amp;rft.isbn=978-0-215-05239-1&amp;rft.au=Great+Britain%3A+Parliament%3A+House+of+Commons%3A+Health+Committee&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D3d-bsIthzCYC%26pg%3DPA7&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nice.org.uk/about\">\"About\"</a>. <i>nice.org.uk</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=nice.org.uk&amp;rft.atitle=About&amp;rft_id=https%3A%2F%2Fwww.nice.org.uk%2Fabout&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation pressrelease\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.opsi.gov.uk/si/si1999/uksi_19990220_en.pdf\">\"The National Institute for Clinical Excellence (Establishment and Constitution) Order 1999\"</a> <span style=\"font-size:85%;\">(PDF)</span> (Press release). <a href=\"/wiki/Office_of_Public_Sector_Information\" title=\"Office of Public Sector Information\">Office of Public Sector Information</a>. 1999-02-02<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-09-18</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+National+Institute+for+Clinical+Excellence+%28Establishment+and+Constitution%29+Order+1999&amp;rft.pub=Office+of+Public+Sector+Information&amp;rft.date=1999-02-02&amp;rft_id=http%3A%2F%2Fwww.opsi.gov.uk%2Fsi%2Fsi1999%2Fuksi_19990220_en.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation pressrelease\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.opsi.gov.uk/si/si2005/20050497.htm\">\"The National Institute for Clinical Excellence (Establishment and Constitution) Amendment Order 2005\"</a> (Press release). <a href=\"/wiki/Office_of_Public_Sector_Information\" title=\"Office of Public Sector Information\">Office of Public Sector Information</a>. 2005-03-07<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-09-18</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+National+Institute+for+Clinical+Excellence+%28Establishment+and+Constitution%29+Amendment+Order+2005&amp;rft.pub=Office+of+Public+Sector+Information&amp;rft.date=2005-03-07&amp;rft_id=http%3A%2F%2Fwww.opsi.gov.uk%2Fsi%2Fsi2005%2F20050497.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation pressrelease\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.opsi.gov.uk/si/si2005/20050502.htm\">\"The Special Health Authorities Abolition Order 2005\"</a> (Press release). <a href=\"/wiki/Office_of_Public_Sector_Information\" title=\"Office of Public Sector Information\">Office of Public Sector Information</a>. 2005-03-07<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-09-18</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Special+Health+Authorities+Abolition+Order+2005&amp;rft.pub=Office+of+Public+Sector+Information&amp;rft.date=2005-03-07&amp;rft_id=http%3A%2F%2Fwww.opsi.gov.uk%2Fsi%2Fsi2005%2F20050502.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Schlander, Michael (2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.springer.com/public+health/book/978-0-387-71995-5\"><i>Health Technology Assessments by the National Institute for Health and Clinical Excellence</i></a>. New York: <a href=\"/wiki/Springer_Science%2BBusiness_Media\" title=\"Springer Science+Business Media\">Springer Science+Business Media</a>. p.&#160;245. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-387-71995-5\" title=\"Special:BookSources/978-0-387-71995-5\">978-0-387-71995-5</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-11-13</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Health+Technology+Assessments+by+the+National+Institute+for+Health+and+Clinical+Excellence&amp;rft.place=New+York&amp;rft.pages=245&amp;rft.pub=Springer+Science%2BBusiness+Media&amp;rft.date=2007&amp;rft.isbn=978-0-387-71995-5&amp;rft.aulast=Schlander&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fwww.springer.com%2Fpublic%2Bhealth%2Fbook%2F978-0-387-71995-5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.nice.org.uk/about/what-we-do/nice-international\">\"NICE International: what we do\"</a>. <i>nice.org.uk</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 Oct</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=nice.org.uk&amp;rft.atitle=NICE+International%3A+what+we+do&amp;rft_id=http%3A%2F%2Fwww.nice.org.uk%2Fabout%2Fwhat-we-do%2Fnice-international&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Cheng, Tsung-Mei (2009-09-15). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ft.com/cms/s/0/5be67610-9ce2-11de-ab58-00144feabdc0,s01=1.html?nclick_check=1\">\"Nice approach\"</a>. <a href=\"/wiki/Financial_Times\" title=\"Financial Times\">Financial Times</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-09-18</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Nice+approach&amp;rft.date=2009-09-15&amp;rft.aulast=Cheng&amp;rft.aufirst=Tsung-Mei&amp;rft_id=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2F5be67610-9ce2-11de-ab58-00144feabdc0%2Cs01%3D1.html%3Fnclick_check%3D1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.screening.nhs.uk/history\">\"History of the UK NSC\"</a>. <i>screening.nhs.uk</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=screening.nhs.uk&amp;rft.atitle=History+of+the+UK+NSC&amp;rft_id=http%3A%2F%2Fwww.screening.nhs.uk%2Fhistory&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://hansard.millbanksystems.com/commons/1997/nov/03/breast-cancer-screening\">\"Breast Cancer Screening\"</a>. Hansard. November 1997.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Breast+Cancer+Screening&amp;rft.pub=Hansard&amp;rft.date=1997-11&amp;rft_id=http%3A%2F%2Fhansard.millbanksystems.com%2Fcommons%2F1997%2Fnov%2F03%2Fbreast-cancer-screening&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4071083\">[1]</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20110103025308/http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4071083\">Archived</a> January 3, 2011, at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.</span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/Browsable/DH_4936272\"><i>The New NHS: Modern, Dependable</i></a>. Department of Health.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+New+NHS%3A+Modern%2C+Dependable&amp;rft.pub=Department+of+Health&amp;rft_id=http%3A%2F%2Fwww.dh.gov.uk%2Fen%2FPublicationsandstatistics%2FPublications%2FPublicationsPolicyAndGuidance%2FBrowsable%2FDH_4936272&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://publications.parliament.uk/pa/cm199899/cmselect/cmhealth/222/9020406.htm\">\"House of Commons - Health - Minutes of Evidence\"</a>. <i>parliament.uk</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=parliament.uk&amp;rft.atitle=House+of+Commons+-+Health+-+Minutes+of+Evidence&amp;rft_id=https%3A%2F%2Fpublications.parliament.uk%2Fpa%2Fcm199899%2Fcmselect%2Fcmhealth%2F222%2F9020406.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\">NICE put on defensive as ruling on Relenza ends in row over 'leaks' <a href=\"/wiki/Health_Service_Journal\" title=\"Health Service Journal\">Health Service Journal</a>, 7 October 1999</span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\">Milbank Quarterly, September 2001</span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sorenson, C; Drummond, M; Kanavos, P; McGuire, A. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.scribd.com/doc/8737637/National-Institute-for-Health-and-Clinical-Excellence-NICE-How-Does-it-Work-and-What-are-the-Implications-for-the-US-Executive-Summary\">\"National Institute for Health and Clinical Excellence (NICE): How does it work and what are the implications for the U.S.?\"</a>. <a href=\"/w/index.php?title=National_Pharmaceutical_Council&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"National Pharmaceutical Council (page does not exist)\">National Pharmaceutical Council</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2009-09-18</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=National+Institute+for+Health+and+Clinical+Excellence+%28NICE%29%3A+How+does+it+work+and+what+are+the+implications+for+the+U.S.%3F&amp;rft.au=Sorenson%2C+C&amp;rft.au=Drummond%2C+M&amp;rft.au=Kanavos%2C+P&amp;rft.au=McGuire%2C+A&amp;rft_id=https%3A%2F%2Fwww.scribd.com%2Fdoc%2F8737637%2FNational-Institute-for-Health-and-Clinical-Excellence-NICE-How-Does-it-Work-and-What-are-the-Implications-for-the-US-Executive-Summary&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Berg, Sanchia (2006-06-09). <a rel=\"nofollow\" class=\"external text\" href=\"http://news.bbc.co.uk/1/hi/health/5063352.stm\">\"Herceptin: Was patient power key?\"</a>. BBC News<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-11-13</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Herceptin%3A+Was+patient+power+key%3F&amp;rft.date=2006-06-09&amp;rft.aulast=Berg&amp;rft.aufirst=Sanchia&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F1%2Fhi%2Fhealth%2F5063352.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.nice.org.uk/aboutnice/howwework/developingniceclinicalguidelines/nationalcollaboratingcentres/national_collaborating_centres.jsp%7ctitle=About%7cwork=nice.org.uk%7ctitle=About%7cwork=nice.org.uk%7ctitle=About%7cwork=nice.org.uk\">\"About\"</a>. <i>nice.org.uk</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=nice.org.uk&amp;rft.atitle=About&amp;rft_id=http%3A%2F%2Fwww.nice.org.uk%2Faboutnice%2Fhowwework%2Fdevelopingniceclinicalguidelines%2Fnationalcollaboratingcentres%2Fnational_collaborating_centres.jsp%257ctitle%3DAbout%257cwork%3Dnice.org.uk%257ctitle%3DAbout%257cwork%3Dnice.org.uk%257ctitle%3DAbout%257cwork%3Dnice.org.uk&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nice.org.uk/guidance/published?type=guidelines\">\"Guidance List\"</a>. <i>nice.org.uk</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">8 October</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=nice.org.uk&amp;rft.atitle=Guidance+List&amp;rft_id=https%3A%2F%2Fwww.nice.org.uk%2Fguidance%2Fpublished%3Ftype%3Dguidelines&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.hsj.co.uk/news/exclusive-labour-could-make-nice-guidance-mandatory/5076286.article#.VHNoSfmsUk4\">\"Exclusive: Labour could make NICE guidance mandatory\"</a>. Health Service Journal. 30 October 2014<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">24 November</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Exclusive%3A+Labour+could+make+NICE+guidance+mandatory&amp;rft.date=2014-10-30&amp;rft_id=http%3A%2F%2Fwww.hsj.co.uk%2Fnews%2Fexclusive-labour-could-make-nice-guidance-mandatory%2F5076286.article%23.VHNoSfmsUk4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Smith2008-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Smith2008_21-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Peter Smith (2008). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=uzfPI3h4U-AC&amp;pg=PR6\"><i>Guide to the Primary Care Guidelines</i></a>. Radcliffe Publishing. p.&#160;6. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-1-85775-734-7\" title=\"Special:BookSources/978-1-85775-734-7\">978-1-85775-734-7</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Guide+to+the+Primary+Care+Guidelines&amp;rft.pages=6&amp;rft.pub=Radcliffe+Publishing&amp;rft.date=2008&amp;rft.isbn=978-1-85775-734-7&amp;rft.au=Peter+Smith&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DuzfPI3h4U-AC%26pg%3DPR6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ReesSmith2014-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ReesSmith2014_22-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Judith A Rees; Ian Smith; Jennie Watson (2014). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=SMGdAgAAQBAJ&amp;pg=PA192\"><i>Pharmaceutical Practice</i></a>. Elsevier Health Sciences UK. p.&#160;192. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-7020-5282-8\" title=\"Special:BookSources/978-0-7020-5282-8\">978-0-7020-5282-8</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Pharmaceutical+Practice&amp;rft.pages=192&amp;rft.pub=Elsevier+Health+Sciences+UK&amp;rft.date=2014&amp;rft.isbn=978-0-7020-5282-8&amp;rft.au=Judith+A+Rees&amp;rft.au=Ian+Smith&amp;rft.au=Jennie+Watson&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DSMGdAgAAQBAJ%26pg%3DPA192&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Health_Care_Programmes_2005-23\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Health_Care_Programmes_2005_23-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Health_Care_Programmes_2005_23-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">Methods for the Economic Evaluation of Health Care Programmes, Drummond et al (2005)</span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\">NICE guidance, 2008</span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20110925050527/http://www.nice.org.uk/niceMedia/pdf/GuidelinesManualChapter8.pdf\">\"NICE Guideline Manual: Incorporating health economics in guidelines and assessing resource impact\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>nice.org.uk</i>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nice.org.uk/niceMedia/pdf/GuidelinesManualChapter8.pdf\">the original</a> <span style=\"font-size:85%;\">(PDF)</span> on 2011-09-25.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=nice.org.uk&amp;rft.atitle=NICE+Guideline+Manual%3A+Incorporating+health+economics+in+guidelines+and+assessing+resource+impact&amp;rft_id=http%3A%2F%2Fwww.nice.org.uk%2FniceMedia%2Fpdf%2FGuidelinesManualChapter8.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Boseley, S; Sparrow, A (4 November 2008). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.theguardian.com/politics/2008/nov/04/nhs-health-cancer-topup-treatment\">\"Johnson lifts NHS ban on top-up treatment\"</a>. <i><a href=\"/wiki/The_Guardian\" title=\"The Guardian\">The Guardian</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 September</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=Johnson+lifts+NHS+ban+on+top-up+treatment&amp;rft.date=2008-11-04&amp;rft.aulast=Boseley&amp;rft.aufirst=S&amp;rft.au=Sparrow%2C+A&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fpolitics%2F2008%2Fnov%2F04%2Fnhs-health-cancer-topup-treatment&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-27\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Appraisal Committee. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20120327103851/http://www.nice.org.uk/nicemedia/live/11937/43868/43868.pdf\">\"Final appraisal determination: Lenalidomide for the treatment of multiple myeloma in people who have received at least one prior therapy\"</a> <span style=\"font-size:85%;\">(PDF)</span>. nice.org.uk. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nice.org.uk/nicemedia/live/11937/43868/43868.pdf\">the original</a> <span style=\"font-size:85%;\">(PDF)</span> on 2012-03-27<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2011-05-13</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Final+appraisal+determination%3A+Lenalidomide+for+the+treatment+of+multiple+myeloma+in+people+who+have+received+at+least+one+prior+therapy&amp;rft.au=Appraisal+Committee&amp;rft_id=http%3A%2F%2Fwww.nice.org.uk%2Fnicemedia%2Flive%2F11937%2F43868%2F43868.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.nice.org.uk/newsroom/features/measuringeffectivenessandcosteffectivenesstheqaly.jsp\">Measuring effectiveness and quality effectiveness - the QALY</a> National Institute for clinical effectiveness</span>\n</li>\n<li id=\"cite_note-Quality_Adjusted_Life_Year-29\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Quality_Adjusted_Life_Year_29-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Quality_Adjusted_Life_Year_29-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.nice.org.uk/newsroom/features/measuringeffectivenessandcosteffectivenesstheqaly.jsp%7ctitle=News%7cwork=nice.org.uk%7ctitle=News%7cwork=nice.org.uk%7ctitle=News%7cwork=nice.org.uk\">\"News\"</a>. <i>nice.org.uk</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=nice.org.uk&amp;rft.atitle=News&amp;rft_id=http%3A%2F%2Fwww.nice.org.uk%2Fnewsroom%2Ffeatures%2Fmeasuringeffectivenessandcosteffectivenesstheqaly.jsp%257ctitle%3DNews%257cwork%3Dnice.org.uk%257ctitle%3DNews%257cwork%3Dnice.org.uk%257ctitle%3DNews%257cwork%3Dnice.org.uk&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-30\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Devlin, N; Parkin, D. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.city.ac.uk/__data/assets/pdf_file/0015/90501/0301_devlin-parkin.pdf\">\"Does NICE have a cost effectiveness threshold and what other factors influence its decisions? A discrete choice analysis\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <a href=\"/wiki/City_University,_London\" class=\"mw-redirect\" title=\"City University, London\">City University, London</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2014-11-20</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Does+NICE+have+a+cost+effectiveness+threshold+and+what+other+factors+influence+its+decisions%3F+A+discrete+choice+analysis.&amp;rft.aulast=Devlin&amp;rft.aufirst=N&amp;rft.au=Parkin%2C+D.&amp;rft_id=http%3A%2F%2Fwww.city.ac.uk%2F&#95;_data%2Fassets%2Fpdf_file%2F0015%2F90501%2F0301_devlin-parkin.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://publications.parliament.uk/pa/cm200708/cmselect/cmhealth/27/27.pdf\">\"House of Commons Health Committee: National Institute for Health and Clinical Excellence - First Report of Session 2007-08\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>publications.parliament.uk</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=publications.parliament.uk&amp;rft.atitle=House+of+Commons+Health+Committee%3A+National+Institute+for+Health+and+Clinical+Excellence+-+First+Report+of+Session+2007-08&amp;rft_id=https%3A%2F%2Fpublications.parliament.uk%2Fpa%2Fcm200708%2Fcmselect%2Fcmhealth%2F27%2F27.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-32\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20130127204213/http://www.hfea.gov.uk/fertility-treatment-cost-nhs.html\">\"NHS IVF and Fertility Treatment \u2013 Funding Options\"</a>. Hfea.gov.uk. 2015-01-06. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.hfea.gov.uk/fertility-treatment-cost-nhs.html\">the original</a> on 2013-01-27<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-09-05</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=NHS+IVF+and+Fertility+Treatment+%E2%80%93+Funding+Options&amp;rft.pub=Hfea.gov.uk&amp;rft.date=2015-01-06&amp;rft_id=http%3A%2F%2Fwww.hfea.gov.uk%2Ffertility-treatment-cost-nhs.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-33\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation pressrelease\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.rnib.org.uk/aboutus/mediacentre/mediareleases/media2007/Pages/mediarelease14jun2007.aspx\">\"Media release (14 June 2007)\"</a> (Press release). <a href=\"/wiki/Royal_National_Institute_of_Blind_People\" title=\"Royal National Institute of Blind People\">Royal National Institute of Blind People</a>. 2007-08-08<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-11-13</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Media+release+%2814+June+2007%29&amp;rft.pub=Royal+National+Institute+of+Blind+People&amp;rft.date=2007-08-08&amp;rft_id=http%3A%2F%2Fwww.rnib.org.uk%2Faboutus%2Fmediacentre%2Fmediareleases%2Fmedia2007%2FPages%2Fmediarelease14jun2007.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-34\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ft.com/cms/s/0/d00c4a02-b784-11e4-981d-00144feab7de.html#axzz3ldCBJUxL\">\"Expensive drugs cost lives, claims report\"</a>. Financial Times. 19 February 2015<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">13 September</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Expensive+drugs+cost+lives%2C+claims+report&amp;rft.date=2015-02-19&amp;rft_id=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2Fd00c4a02-b784-11e4-981d-00144feab7de.html%23axzz3ldCBJUxL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-35\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.hsj.co.uk/topics/policy-and-regulation/nhs-england-rollout-of-ground-breaking-drugs-changes-role-of-nice/7003752.article\">\"NHS England rollout of ground-breaking drugs 'changes role of NICE<span style=\"padding-right:0.2em;\">'</span>\"</a>. Health Service Journal. 4 April 2016<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 May</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=NHS+England+rollout+of+ground-breaking+drugs+%27changes+role+of+NICE%27&amp;rft.date=2016-04-04&amp;rft_id=http%3A%2F%2Fwww.hsj.co.uk%2Ftopics%2Fpolicy-and-regulation%2Fnhs-england-rollout-of-ground-breaking-drugs-changes-role-of-nice%2F7003752.article&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.gaytimes.co.uk/life/36173/philip-baldwin-need-better-access-treatment-gay-men-living-hiv-hep-c/\">\"Philip Christopher Baldwin: \"We need better access to treatment for gay men living with HIV and Hep C<span style=\"padding-right:0.2em;\">\"</span>\"</a>. Gay Times. 11 May 2016<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">14 May</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Philip+Christopher+Baldwin%3A+%22We+need+better+access+to+treatment+for+gay+men+living+with+HIV+and+Hep+C%22&amp;rft.date=2016-05-11&amp;rft_id=https%3A%2F%2Fwww.gaytimes.co.uk%2Flife%2F36173%2Fphilip-baldwin-need-better-access-treatment-gay-men-living-hiv-hep-c%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"Further_reading\">Further reading</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=National_Institute_for_Health_and_Care_Excellence&amp;action=edit&amp;section=12\" title=\"Edit section: Further reading\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><span class=\"official-website\"><span class=\"url\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.nice.org.uk\">Official website</a></span></span></li>\n<li><cite class=\"citation book\">Timmins, Nicholas; Rawlins, Sir Michael; Appleby, John (2016). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.hitap.net/en/documents/164742\"><i>A Terrible Beauty: A Short History of NICE The National Institute of Health and Care Excellence</i></a>. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-616-11-2821-0\" title=\"Special:BookSources/978-616-11-2821-0\">978-616-11-2821-0</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=A+Terrible+Beauty%3A+A+Short+History+of+NICE+The+National+Institute+of+Health+and+Care+Excellence&amp;rft.date=2016&amp;rft.isbn=978-616-11-2821-0&amp;rft.aulast=Timmins&amp;rft.aufirst=Nicholas&amp;rft.au=Rawlins%2C+Sir+Michael&amp;rft.au=Appleby%2C+John&amp;rft_id=http%3A%2F%2Fwww.hitap.net%2Fen%2Fdocuments%2F164742&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANational+Institute+for+Health+and+Care+Excellence\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20110114024624/http://www.niceconference.org.uk/home\">NICE annual conference and exhibition</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://vimeo.com/4796083\">The Price of Life, BBC Documentary about NICE</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.timesonline.co.uk/tol/news/uk/health/article6430926.ece\">The Unbearable Cost of Living, Sunday Times (London)</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.niceconference.org.uk/\">NICE Annual Conference</a> organised by <a href=\"/wiki/EMAP\" class=\"mw-redirect\" title=\"EMAP\">i2i events group</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://www.youtube.com/watch?v=nDY4SoU20mI\">Video, 9:19 minutes</a>: \"What is the NICE threshold?\", Centre for Health Economics, University of York</li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Department_of_Health_of_the_United_Kingdom\" style=\"padding:3px\"><table class=\"nowraplinks hlist collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Department_of_Health_(United_Kingdom)\" title=\"Template:Department of Health (United Kingdom)\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Department_of_Health_(United_Kingdom)\" title=\"Template talk:Department of Health (United Kingdom)\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Department_of_Health_(United_Kingdom)&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Department_of_Health_of_the_United_Kingdom\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Department_of_Health_(United_Kingdom)\" class=\"mw-redirect\" title=\"Department of Health (United Kingdom)\">Department of Health of the United Kingdom</a></div></th></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div id=\"*_Headquarters:_Richmond_House&amp;#10;*_Skipton_House&amp;#10;*_Quarry_House\">\n<ul><li>Headquarters: <a href=\"/wiki/Richmond_House\" title=\"Richmond House\">Richmond House</a></li>\n<li><a href=\"/wiki/Skipton_House\" title=\"Skipton House\">Skipton House</a></li>\n<li><a href=\"/wiki/Quarry_Hill,_Leeds\" title=\"Quarry Hill, Leeds\">Quarry House</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Department_of_Health_and_Social_Care#Ministers\" title=\"Department of Health and Social Care\">Ministers</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Secretary_of_State_for_Health\" class=\"mw-redirect\" title=\"Secretary of State for Health\">Secretary of State for Health</a></li>\n<li>Minister of State for Health</li>\n<li>Minister of State for Care and Support</li>\n<li>Parliamentary Under-Secretary of State for Public Health</li>\n<li>Parliamentary Under-Secretary of State for Quality</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Executive_Agency\" class=\"mw-redirect\" title=\"Executive Agency\">Executive agencies</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Medicines_and_Healthcare_Products_Regulatory_Agency\" class=\"mw-redirect\" title=\"Medicines and Healthcare Products Regulatory Agency\">Medicines and Healthcare Products Regulatory Agency</a></li>\n<li><a href=\"/wiki/Public_Health_England\" title=\"Public Health England\">Public Health England</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Executive <a href=\"/wiki/Non-Departmental_Public_Body\" class=\"mw-redirect\" title=\"Non-Departmental Public Body\">Non-departmental<br />public bodies</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Care_Quality_Commission\" title=\"Care Quality Commission\">Care Quality Commission</a></li>\n<li><a href=\"/wiki/Health_and_Social_Care_Information_Centre\" class=\"mw-redirect\" title=\"Health and Social Care Information Centre\">Health and Social Care Information Centre</a></li>\n<li><a href=\"/wiki/Health_Education_England\" title=\"Health Education England\">Health Education England</a></li>\n<li><a href=\"/wiki/Health_Research_Authority\" title=\"Health Research Authority\">Health Research Authority</a></li>\n<li><a href=\"/wiki/Human_Fertilisation_and_Embryology_Authority\" title=\"Human Fertilisation and Embryology Authority\">Human Fertilisation and Embryology Authority</a></li>\n<li><a href=\"/wiki/Human_Tissue_Authority\" title=\"Human Tissue Authority\">Human Tissue Authority</a></li>\n<li><a class=\"mw-selflink selflink\">National Institute for Health and Care Excellence</a></li>\n<li><a href=\"/wiki/NHS_England\" title=\"NHS England\">NHS England</a></li>\n<li><a href=\"/wiki/NHS_Blood_and_Transplant\" title=\"NHS Blood and Transplant\">NHS Blood and Transplant</a></li>\n<li><a href=\"/wiki/NHS_Business_Services_Authority\" title=\"NHS Business Services Authority\">NHS Business Services Authority</a></li>\n<li><a href=\"/wiki/NHS_Litigation_Authority\" class=\"mw-redirect\" title=\"NHS Litigation Authority\">NHS Litigation Authority</a></li>\n<li><a href=\"/wiki/NHS_Improvement\" title=\"NHS Improvement\">NHS Improvement</a></li></ul>\n</div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div><img alt=\"Category\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/16px-Folder_Hexagonal_Icon.svg.png\" title=\"Category\" width=\"16\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/24px-Folder_Hexagonal_Icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/32px-Folder_Hexagonal_Icon.svg.png 2x\" data-file-width=\"36\" data-file-height=\"31\" /> <b><a href=\"/wiki/Category:Department_of_Health_(United_Kingdom)\" title=\"Category:Department of Health (United Kingdom)\">Category</a></b></div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2274\nCached time: 20180918004725\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.484 seconds\nReal time usage: 0.602 seconds\nPreprocessor visited node count: 2856/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 83113/2097152 bytes\nTemplate argument size: 2669/2097152 bytes\nHighest expansion depth: 12/40\nExpensive parser function count: 7/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 36668/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.225/10.000 seconds\nLua memory usage: 6.22 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  487.585      1 -total\n 41.11%  200.448      1 Template:Reflist\n 14.65%   71.439      1 Template:Infobox_government_agency\n 11.33%   55.235      6 Template:Cite_book\n 10.97%   53.470      1 Template:Infobox\n  8.12%   39.595      4 Template:Fix\n  7.86%   38.338     11 Template:Cite_web\n  6.42%   31.291      1 Template:Redirect\n  6.16%   30.028      1 Template:More_citations_needed\n  6.13%   29.873      2 Template:Ambox\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:429680-0!canonical and timestamp 20180918004724 and revision id 856187413\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D8%A7%D9%84%D9%85%D8%B9%D9%87%D8%AF_%D8%A7%D9%84%D9%88%D8%B7%D9%86%D9%8A_%D9%84%D9%84%D8%B5%D8%AD%D8%A9_%D9%88%D8%AA%D9%81%D9%88%D9%82_%D8%A7%D9%84%D8%B1%D8%B9%D8%A7%D9%8A%D8%A9","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u0627\u0644\u0645\u0639\u0647\u062f \u0627\u0644\u0648\u0637\u0646\u064a \u0644\u0644\u0635\u062d\u0629 \u0648\u062a\u0641\u0648\u0642 \u0627\u0644\u0631\u0639\u0627\u064a\u0629"},{"lang":"cy","url":"https://cy.wikipedia.org/wiki/National_Institute_for_Health_and_Care_Excellence","langname":"Welsh","autonym":"Cymraeg","*":"National Institute for Health and Care Excellence"},{"lang":"de","url":"https://de.wikipedia.org/wiki/National_Institute_for_Health_and_Care_Excellence","langname":"German","autonym":"Deutsch","*":"National Institute for Health and Care Excellence"},{"lang":"it","url":"https://it.wikipedia.org/wiki/National_Institute_for_Health_and_Care_Excellence","langname":"Italian","autonym":"italiano","*":"National Institute for Health and Care Excellence"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E8%8B%B1%E5%9B%BD%E5%9B%BD%E7%AB%8B%E5%8C%BB%E7%99%82%E6%8A%80%E8%A1%93%E8%A9%95%E4%BE%A1%E6%A9%9F%E6%A7%8B","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u82f1\u56fd\u56fd\u7acb\u533b\u7642\u6280\u8853\u8a55\u4fa1\u6a5f\u69cb"},{"lang":"no","url":"https://no.wikipedia.org/wiki/National_Institute_for_Health_and_Care_Excellence","langname":"Norwegian","autonym":"norsk","*":"National Institute for Health and Care Excellence"},{"lang":"uk","url":"https://uk.wikipedia.org/wiki/%D0%9D%D0%B0%D1%86%D1%96%D0%BE%D0%BD%D0%B0%D0%BB%D1%8C%D0%BD%D0%B8%D0%B9_%D1%96%D0%BD%D1%81%D1%82%D0%B8%D1%82%D1%83%D1%82_%D0%B7%D0%B4%D0%BE%D1%80%D0%BE%D0%B2%27%D1%8F_%D1%96_%D0%B4%D0%BE%D1%81%D0%BA%D0%BE%D0%BD%D0%B0%D0%BB%D0%BE%D1%81%D1%82%D1%96_%D0%B4%D0%BE%D0%BF%D0%BE%D0%BC%D0%BE%D0%B3%D0%B8","langname":"Ukrainian","autonym":"\u0443\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u0430","*":"\u041d\u0430\u0446\u0456\u043e\u043d\u0430\u043b\u044c\u043d\u0438\u0439 \u0456\u043d\u0441\u0442\u0438\u0442\u0443\u0442 \u0437\u0434\u043e\u0440\u043e\u0432'\u044f \u0456 \u0434\u043e\u0441\u043a\u043e\u043d\u0430\u043b\u043e\u0441\u0442\u0456 \u0434\u043e\u043f\u043e\u043c\u043e\u0433\u0438"}],"categories":[{"sortkey":"","hidden":"","*":"Webarchive_template_wayback_links"},{"sortkey":"National Institute For Health And Clinical Excellence","hidden":"","*":"Articles_needing_additional_references_from_April_2014"},{"sortkey":"National Institute For Health And Clinical Excellence","hidden":"","*":"All_articles_needing_additional_references"},{"sortkey":"National Institute For Health And Clinical Excellence","hidden":"","*":"Vague_or_ambiguous_geographic_scope_from_July_2013"},{"sortkey":"National Institute For Health And Clinical Excellence","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"National Institute For Health And Clinical Excellence","hidden":"","*":"Articles_with_unsourced_statements_from_April_2014"},{"sortkey":"National Institute For Health And Clinical Excellence","hidden":"","*":"Articles_needing_additional_references_from_September_2013"},{"sortkey":"National Institute For Health And Clinical Excellence","hidden":"","*":"Wikipedia_articles_in_need_of_updating_from_December_2014"},{"sortkey":"National Institute For Health And Clinical Excellence","hidden":"","*":"All_Wikipedia_articles_in_need_of_updating"},{"sortkey":"National Institute For Health And Clinical Excellence","hidden":"","*":"Articles_with_unsourced_statements_from_October_2014"},{"sortkey":"National Institute For Health And Clinical Excellence","*":"1999_establishments_in_the_United_Kingdom"},{"sortkey":"National Institute For Health And Clinical Excellence","*":"Clinical_pharmacology"},{"sortkey":"National Institute For Health And Clinical Excellence","*":"Healthcare_quality"},{"sortkey":"National Institute For Health And Clinical Excellence","*":"National_Health_Service_(England)"},{"sortkey":"National Institute For Health And Clinical Excellence","*":"Non-departmental_public_bodies_of_the_United_Kingdom_government"},{"sortkey":"National Institute For Health And Clinical Excellence","*":"NHS_Wales"},{"sortkey":"National Institute For Health And Clinical Excellence","*":"Organizations_established_in_1999"},{"sortkey":"National Institute For Health And Clinical Excellence","*":"Health_promotion"},{"sortkey":"National Institute For Health And Clinical Excellence","*":"Public_health_education"},{"sortkey":"National Institute For Health And Clinical Excellence","*":"Health_education_organizations"},{"sortkey":"National Institute For Health And Clinical Excellence","hidden":"","*":"Articles_containing_video_clips"},{"sortkey":"National Institute For Health And Clinical Excellence","*":"Health_economics"},{"sortkey":"National Institute For Health And Clinical Excellence","*":"National_agencies_for_drug_regulation"}],"links":[{"ns":0,"exists":"","*":"NICE"},{"ns":0,"exists":"","*":"Alan Johnson"},{"ns":0,"exists":"","*":"Alan Milburn"},{"ns":0,"exists":"","*":"Alzheimer's disease"},{"ns":0,"exists":"","*":"Andrew Dillon"},{"ns":0,"exists":"","*":"Andy Burnham"},{"ns":0,"exists":"","*":"Bevacizumab"},{"ns":0,"exists":"","*":"Calman-Hine report"},{"ns":0,"exists":"","*":"Cancer Drugs Fund"},{"ns":0,"exists":"","*":"Care Quality Commission"},{"ns":0,"exists":"","*":"Chairman"},{"ns":0,"exists":"","*":"Chemotherapy"},{"ns":0,"exists":"","*":"Cirrhosis"},{"ns":0,"exists":"","*":"City University, London"},{"ns":0,"exists":"","*":"Clinical commissioning group"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Department for Education"},{"ns":0,"exists":"","*":"Department of Health (United Kingdom)"},{"ns":0,"exists":"","*":"Department of Health and Social Care"},{"ns":0,"exists":"","*":"Discounting"},{"ns":0,"exists":"","*":"Donepezil"},{"ns":0,"exists":"","*":"EMAP"},{"ns":0,"exists":"","*":"EPPI-Centre"},{"ns":0,"exists":"","*":"Economic evaluation"},{"ns":0,"exists":"","*":"Executive Agency"},{"ns":0,"exists":"","*":"Fibrosis"},{"ns":0,"exists":"","*":"Financial Times"},{"ns":0,"exists":"","*":"Frank Dobson"},{"ns":0,"exists":"","*":"Galantamine"},{"ns":0,"exists":"","*":"Glaxo Wellcome"},{"ns":0,"exists":"","*":"Health Education England"},{"ns":0,"exists":"","*":"Health Research Authority"},{"ns":0,"exists":"","*":"Health Select Committee"},{"ns":0,"exists":"","*":"Health Service Journal"},{"ns":0,"exists":"","*":"Health and Social Care Act 2012"},{"ns":0,"exists":"","*":"Health and Social Care Information Centre"},{"ns":0,"exists":"","*":"Health care rationing"},{"ns":0,"exists":"","*":"Health promotion"},{"ns":0,"exists":"","*":"Health technology"},{"ns":0,"exists":"","*":"Health technology assessment"},{"ns":0,"exists":"","*":"Hepatitis C"},{"ns":0,"exists":"","*":"Home care"},{"ns":0,"exists":"","*":"Human Fertilisation and Embryology Authority"},{"ns":0,"exists":"","*":"Human Tissue Authority"},{"ns":0,"exists":"","*":"Incremental cost-effectiveness ratio"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"John Major"},{"ns":0,"exists":"","*":"Karl Claxton"},{"ns":0,"exists":"","*":"Kenneth Calman"},{"ns":0,"exists":"","*":"Lenalidomide"},{"ns":0,"exists":"","*":"Lobbying"},{"ns":0,"exists":"","*":"London"},{"ns":0,"exists":"","*":"Macular degeneration"},{"ns":0,"exists":"","*":"Margaret Jay, Baroness Jay of Paddington"},{"ns":0,"exists":"","*":"Medicines and Healthcare Products Regulatory Agency"},{"ns":0,"exists":"","*":"Memantine"},{"ns":0,"exists":"","*":"Michael Rawlins"},{"ns":0,"exists":"","*":"Muir Gray"},{"ns":0,"exists":"","*":"NHS Blood and Transplant"},{"ns":0,"exists":"","*":"NHS Business Services Authority"},{"ns":0,"exists":"","*":"NHS England"},{"ns":0,"exists":"","*":"NHS Improvement"},{"ns":0,"exists":"","*":"NHS Litigation Authority"},{"ns":0,"exists":"","*":"NHS Wales"},{"ns":0,"exists":"","*":"NHS primary care trust"},{"ns":0,"exists":"","*":"NHS special health authority"},{"ns":0,"exists":"","*":"NICE (disambiguation)"},{"ns":0,"exists":"","*":"National Clinical Guideline Centre"},{"ns":0,"exists":"","*":"National Collaborating Centre for Mental Health"},{"ns":0,"exists":"","*":"National Health Service (England)"},{"ns":0,"exists":"","*":"National Institute for Health Research"},{"ns":0,"exists":"","*":"Non-Departmental Public Body"},{"ns":0,"exists":"","*":"Non-departmental public body"},{"ns":0,"exists":"","*":"Office of Public Sector Information"},{"ns":0,"exists":"","*":"Opportunity cost"},{"ns":0,"exists":"","*":"Postcode lottery"},{"ns":0,"exists":"","*":"Public Health England"},{"ns":0,"exists":"","*":"Quality-adjusted life year"},{"ns":0,"exists":"","*":"Quarry Hill, Leeds"},{"ns":0,"exists":"","*":"Radiotherapy"},{"ns":0,"exists":"","*":"Relenza"},{"ns":0,"exists":"","*":"Renal cell carcinoma"},{"ns":0,"exists":"","*":"Richmond House"},{"ns":0,"exists":"","*":"Rivastigmine"},{"ns":0,"exists":"","*":"Royal London Hospital"},{"ns":0,"exists":"","*":"Royal National Institute of Blind People"},{"ns":0,"exists":"","*":"Scottish Intercollegiate Guideline Network"},{"ns":0,"exists":"","*":"Scottish Medicines Consortium"},{"ns":0,"exists":"","*":"Secretary of State for Health"},{"ns":0,"exists":"","*":"Shadow price"},{"ns":0,"exists":"","*":"Skipton House"},{"ns":0,"exists":"","*":"Social Care Institute for Excellence"},{"ns":0,"exists":"","*":"Social care"},{"ns":0,"exists":"","*":"Social work"},{"ns":0,"exists":"","*":"Sofosbuvir"},{"ns":0,"exists":"","*":"Sorafenib"},{"ns":0,"exists":"","*":"Springer Science+Business Media"},{"ns":0,"exists":"","*":"Sunitinib"},{"ns":0,"exists":"","*":"Temsirolimus"},{"ns":0,"exists":"","*":"Tessa Jowell"},{"ns":0,"exists":"","*":"The Guardian"},{"ns":0,"exists":"","*":"Trevor Sheldon"},{"ns":0,"exists":"","*":"UK National Screening Committee"},{"ns":0,"exists":"","*":"United Kingdom"},{"ns":0,"exists":"","*":"University of York"},{"ns":0,"exists":"","*":"Wayback Machine"},{"ns":0,"exists":"","*":"Welsh Assembly"},{"ns":0,"exists":"","*":"Welsh NHS"},{"ns":0,"exists":"","*":"White paper"},{"ns":0,"*":"National Pharmaceutical Council"},{"ns":0,"*":"National Collaborating Centre for Cancer"},{"ns":0,"*":"National Collaborating Centre for Women and Children\u00b4s Health"},{"ns":0,"*":"Personal Social Services Research Unit"},{"ns":14,"exists":"","*":"Category:Articles needing additional references from April 2014"},{"ns":14,"exists":"","*":"Category:Vague or ambiguous geographic scope from July 2013"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from April 2014"},{"ns":14,"exists":"","*":"Category:Articles needing additional references from September 2013"},{"ns":14,"exists":"","*":"Category:Wikipedia articles in need of updating from December 2014"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from October 2014"},{"ns":14,"exists":"","*":"Category:Department of Health (United Kingdom)"},{"ns":10,"exists":"","*":"Template:Department of Health (United Kingdom)"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"},{"ns":4,"exists":"","*":"Wikipedia:Citing sources"},{"ns":4,"exists":"","*":"Wikipedia:Manual of Style/Dates and numbers"},{"ns":4,"exists":"","*":"Wikipedia:Naming conventions (geographic names)"},{"ns":4,"exists":"","*":"Wikipedia:Verifiability"},{"ns":11,"exists":"","*":"Template talk:Department of Health (United Kingdom)"},{"ns":12,"exists":"","*":"Help:Introduction to referencing with Wiki Markup/1"},{"ns":12,"exists":"","*":"Help:Maintenance template removal"}],"templates":[{"ns":10,"exists":"","*":"Template:Redirect"},{"ns":10,"exists":"","*":"Template:Infobox government agency"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Br separated entries"},{"ns":10,"exists":"","*":"Template:Url"},{"ns":10,"exists":"","*":"Template:URL"},{"ns":10,"exists":"","*":"Template:Unbulleted list"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:More citations needed"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Where"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Unreferenced section"},{"ns":10,"exists":"","*":"Template:Unreferenced"},{"ns":10,"exists":"","*":"Template:Update inline"},{"ns":10,"exists":"","*":"Template:DMCA"},{"ns":10,"exists":"","*":"Template:Dated maintenance category"},{"ns":10,"exists":"","*":"Template:FULLROOTPAGENAME"},{"ns":10,"exists":"","*":"Template:Ns has subpages"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite pressrelease"},{"ns":10,"exists":"","*":"Template:Cite press release"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Webarchive"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Official website"},{"ns":10,"exists":"","*":"Template:Department of Health (United Kingdom)"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:Icon"},{"ns":828,"exists":"","*":"Module:Redirect hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Redirect"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:Separated entries"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:URL"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:Ns has subpages"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Webarchive"},{"ns":828,"exists":"","*":"Module:Webarchive/data"},{"ns":828,"exists":"","*":"Module:Official website"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Icon"},{"ns":828,"exists":"","*":"Module:Icon/data"},{"ns":0,"exists":"","*":"NICE"}],"images":["National_Institute_for_Health_and_Care_Excellence.svg","Question_book-new.svg","Evidence-informed-health-policy-4---Case-descriptions-of-organizations-that-support-the-use-of-1748-5908-3-56-S8.ogv","Folder_Hexagonal_Icon.svg"],"externallinks":["https://books.google.com/books?id=3d-bsIthzCYC&pg=PA7","https://www.nice.org.uk/about","http://www.opsi.gov.uk/si/si1999/uksi_19990220_en.pdf","http://www.opsi.gov.uk/si/si2005/20050497.htm","http://www.opsi.gov.uk/si/si2005/20050502.htm","https://www.springer.com/public+health/book/978-0-387-71995-5","http://www.nice.org.uk/about/what-we-do/nice-international","http://www.ft.com/cms/s/0/5be67610-9ce2-11de-ab58-00144feabdc0,s01=1.html?nclick_check=1","http://www.screening.nhs.uk/history","http://hansard.millbanksystems.com/commons/1997/nov/03/breast-cancer-screening","http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4071083","https://web.archive.org/web/20110103025308/http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4071083","http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/Browsable/DH_4936272","https://publications.parliament.uk/pa/cm199899/cmselect/cmhealth/222/9020406.htm","https://www.scribd.com/doc/8737637/National-Institute-for-Health-and-Clinical-Excellence-NICE-How-Does-it-Work-and-What-are-the-Implications-for-the-US-Executive-Summary","http://news.bbc.co.uk/1/hi/health/5063352.stm","http://www.nice.org.uk/aboutnice/howwework/developingniceclinicalguidelines/nationalcollaboratingcentres/national_collaborating_centres.jsp%7Ctitle=About%7Cwork=nice.org.uk%7Ctitle=About%7Cwork=nice.org.uk%7Ctitle=About%7Cwork=nice.org.uk","https://www.nice.org.uk/guidance/published?type=guidelines","http://www.hsj.co.uk/news/exclusive-labour-could-make-nice-guidance-mandatory/5076286.article#.VHNoSfmsUk4","https://books.google.com/books?id=uzfPI3h4U-AC&pg=PR6","https://books.google.com/books?id=SMGdAgAAQBAJ&pg=PA192","https://web.archive.org/web/20110925050527/http://www.nice.org.uk/niceMedia/pdf/GuidelinesManualChapter8.pdf","http://www.nice.org.uk/niceMedia/pdf/GuidelinesManualChapter8.pdf","https://www.theguardian.com/politics/2008/nov/04/nhs-health-cancer-topup-treatment","https://web.archive.org/web/20120327103851/http://www.nice.org.uk/nicemedia/live/11937/43868/43868.pdf","http://www.nice.org.uk/nicemedia/live/11937/43868/43868.pdf","http://www.nice.org.uk/newsroom/features/measuringeffectivenessandcosteffectivenesstheqaly.jsp","http://www.nice.org.uk/newsroom/features/measuringeffectivenessandcosteffectivenesstheqaly.jsp%7Ctitle=News%7Cwork=nice.org.uk%7Ctitle=News%7Cwork=nice.org.uk%7Ctitle=News%7Cwork=nice.org.uk","http://www.city.ac.uk/__data/assets/pdf_file/0015/90501/0301_devlin-parkin.pdf","https://publications.parliament.uk/pa/cm200708/cmselect/cmhealth/27/27.pdf","https://web.archive.org/web/20130127204213/http://www.hfea.gov.uk/fertility-treatment-cost-nhs.html","http://www.hfea.gov.uk/fertility-treatment-cost-nhs.html","http://www.rnib.org.uk/aboutus/mediacentre/mediareleases/media2007/Pages/mediarelease14jun2007.aspx","http://www.ft.com/cms/s/0/d00c4a02-b784-11e4-981d-00144feab7de.html#axzz3ldCBJUxL","http://www.hsj.co.uk/topics/policy-and-regulation/nhs-england-rollout-of-ground-breaking-drugs-changes-role-of-nice/7003752.article","https://www.gaytimes.co.uk/life/36173/philip-baldwin-need-better-access-treatment-gay-men-living-hiv-hep-c/","http://www.nice.org.uk","http://www.hitap.net/en/documents/164742","https://web.archive.org/web/20110114024624/http://www.niceconference.org.uk/home","http://vimeo.com/4796083","http://www.timesonline.co.uk/tol/news/uk/health/article6430926.ece","http://www.niceconference.org.uk/","https://www.youtube.com/watch?v=nDY4SoU20mI"],"sections":[{"toclevel":1,"level":"2","line":"Policy history","number":"1","index":"1","fromtitle":"National_Institute_for_Health_and_Care_Excellence","byteoffset":4734,"anchor":"Policy_history"},{"toclevel":1,"level":"2","line":"Technology appraisals","number":"2","index":"2","fromtitle":"National_Institute_for_Health_and_Care_Excellence","byteoffset":9099,"anchor":"Technology_appraisals"},{"toclevel":1,"level":"2","line":"Clinical guidelines","number":"3","index":"3","fromtitle":"National_Institute_for_Health_and_Care_Excellence","byteoffset":12544,"anchor":"Clinical_guidelines"},{"toclevel":1,"level":"2","line":"Social care guidance","number":"4","index":"4","fromtitle":"National_Institute_for_Health_and_Care_Excellence","byteoffset":16189,"anchor":"Social_care_guidance"},{"toclevel":1,"level":"2","line":"Cost\u2013effectiveness","number":"5","index":"5","fromtitle":"National_Institute_for_Health_and_Care_Excellence","byteoffset":19105,"anchor":"Cost\u2013effectiveness"},{"toclevel":2,"level":"3","line":"Quality-adjusted life years","number":"5.1","index":"6","fromtitle":"National_Institute_for_Health_and_Care_Excellence","byteoffset":20365,"anchor":"Quality-adjusted_life_years"},{"toclevel":2,"level":"3","line":"Cost per quality-adjusted life year gained","number":"5.2","index":"7","fromtitle":"National_Institute_for_Health_and_Care_Excellence","byteoffset":23038,"anchor":"Cost_per_quality-adjusted_life_year_gained"},{"toclevel":2,"level":"3","line":"Basis of recommendations","number":"5.3","index":"8","fromtitle":"National_Institute_for_Health_and_Care_Excellence","byteoffset":25407,"anchor":"Basis_of_recommendations"},{"toclevel":1,"level":"2","line":"Criticism","number":"6","index":"9","fromtitle":"National_Institute_for_Health_and_Care_Excellence","byteoffset":28659,"anchor":"Criticism"},{"toclevel":1,"level":"2","line":"See also","number":"7","index":"10","fromtitle":"National_Institute_for_Health_and_Care_Excellence","byteoffset":33879,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"8","index":"11","fromtitle":"National_Institute_for_Health_and_Care_Excellence","byteoffset":34166,"anchor":"References"},{"toclevel":1,"level":"2","line":"Further reading","number":"9","index":"12","fromtitle":"National_Institute_for_Health_and_Care_Excellence","byteoffset":34208,"anchor":"Further_reading"}],"parsewarnings":[],"displaytitle":"National Institute for Health and Care Excellence","iwlinks":[],"properties":[{"name":"defaultsort","*":"National Institute For Health And Clinical Excellence"},{"name":"wikibase_item","*":"Q3425168"}]}}